Informed consent cornerstone of research

April 1, 2004

Dr. Smarts wants to start performing clinical research studies in his office. He assumes that such research will bring him the press notoriety that will boost his lagging dermatology practice. Dr. Smarts begins to evaluate a new substance for the treatment of psoriasis not approved by the FDA. He verbally tells his patients they are research "guinea pigs"; he lets them know he is able to obtain the as-of-now unobtainable material from a local compounding pharmacy.